South Asian Journal of Cancer (Apr 2024)
A Retrospective Analysis of <i>BCR-ABL1</i> Kinase Domain Mutations in the Frontline Drug Intolerant or Resistant Chronic Myeloid Leukemia Patients: An Indian Experience from a High-End Referral Laboratory
- Atreye Majumdar,
- Rahul Katara,
- Avshesh Mishra,
- Aastha Gupta,
- Deepak K. Sharma,
- Aman K. Srivastava,
- Shivani Sharma,
- Ankita Jaiswal,
- Mallika Dixit,
- Vipin Kumar,
- Sachin Kumar,
- Varun Kumar,
- Rahul Sharma,
- Sambit K. Mohanty
Affiliations
- Atreye Majumdar
- Department of Pathology and Laboratory Medicine, CORE Diagnostics, Gurgaon, Haryana, India
- Rahul Katara
- Department of Pathology and Laboratory Medicine, CORE Diagnostics, Gurgaon, Haryana, India
- Avshesh Mishra
- Department of Pathology and Laboratory Medicine, CORE Diagnostics, Gurgaon, Haryana, India
- Aastha Gupta
- Department of Pathology and Laboratory Medicine, CORE Diagnostics, Gurgaon, Haryana, India
- Deepak K. Sharma
- Department of Pathology and Laboratory Medicine, CORE Diagnostics, Gurgaon, Haryana, India
- Aman K. Srivastava
- Department of Pathology and Laboratory Medicine, CORE Diagnostics, Gurgaon, Haryana, India
- Shivani Sharma
- Department of Pathology and Laboratory Medicine, CORE Diagnostics, Gurgaon, Haryana, India
- Ankita Jaiswal
- Department of Pathology and Laboratory Medicine, CORE Diagnostics, Gurgaon, Haryana, India
- Mallika Dixit
- Department of Pathology and Laboratory Medicine, CORE Diagnostics, Gurgaon, Haryana, India
- Vipin Kumar
- Department of Pathology and Laboratory Medicine, CORE Diagnostics, Gurgaon, Haryana, India
- Sachin Kumar
- Department of Pathology and Laboratory Medicine, CORE Diagnostics, Gurgaon, Haryana, India
- Varun Kumar
- Department of Pathology and Laboratory Medicine, CORE Diagnostics, Gurgaon, Haryana, India
- Rahul Sharma
- Department of Pathology and Laboratory Medicine, CORE Diagnostics, Gurgaon, Haryana, India
- Sambit K. Mohanty
- ORCiD
- Department of Pathology and Laboratory Medicine, CORE Diagnostics, Gurgaon, Haryana, India
- DOI
- https://doi.org/10.1055/s-0042-1757911
- Journal volume & issue
-
Vol. 13,
no. 02
pp. 132 – 141
Abstract
No abstracts available.Keywords
- chronic myeloid leukemia
- kinase domain mutations
- BCR-ABL1
- tyrosine kinase inhibitors
- Sanger sequencing
- therapy resistance
